TAK-360 for Idiopathic Hypersomnia

A Study of TAK-360 in Adults With Idiopathic Hypersomnia

Recruiting Phase 2 Interventional Study
Idiopathic Hypersomnia
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
96 (estimated)
Sponsor
Takeda · Industry
Who this trial is looking for

This trial is looking for adults with idiopathic hypersomnia, a condition that makes people very sleepy during the day. Participants will take either the study drug TAK-360 or a placebo to help researchers learn about its safety and effects.

Are You a Good Fit for This Trial?

You may be able to join if

  • I weigh at least 40 kilograms
  • I have a body mass index between 16 and 38
  • I have been diagnosed with idiopathic hypersomnia

You may not be able to join if

  • I have another medical disorder causing excessive daytime sleepiness
  • I have significant thyroid disease
  • I have had cancer in the past 5 years
  • I have a positive test for Hepatitis B, Hepatitis C, or HIV
  • I have a history of head injury or trauma
  • I have a history of epilepsy or seizures
  • I have a history of cerebral ischemia or transient ischemic attack

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Idiopathic Hypersomnia (IH) is a condition where people feel extremely sleepy during the day, especially in the morning, even if they sleep a lot at night. They may have trouble waking up in the morning, no matter how much they sleep (sometimes more than 11 hours per day), and they can't help feeling tired, even after taking daytime naps. Because of this sleepiness, they may have trouble focusing,…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Key Inclusion Criteria: 1. The participant weighs greater than or equal to (≥) 40 kilograms (kg) and has a body mass index (BMI) between 16 and 38 kilograms per meter square (kg/m\^2) \[inclusive\]. 2. The participant has a documented, current diagnosis of IH. Key Exclusion Criteria: 1. The parti…
Contacts

Takeda Contact

+1-877-825-3327

medinfoUS@takeda.com

CONTACT